@article{5c6879728f6f47099507ed4da234d00f,
title = "Readmitted after a seizure-related hospitalization: D{\'e}j{\`a} vu",
author = "Nathalie Jett{\'e} and Meador, {Kimford J.} and Kwon, {Churl Su}",
note = "Funding Information: the current holder of research funding (paid to her academic institutions) for unrelated work from Alberta Health, NINDS (NIH IU54NS100064), and the University of Calgary. K. Meador has received research support from the NIH, Eisai, Medtronics, and Sunovion Pharmaceuticals. The Epilepsy Study Consortium pays Dr. Meador{\textquoteright}s university for his research consultant time related to Eisai, GW Pharmaceuticals, Medtronics, NeuroPace, Novartis, Supernus, Upsher-Smith Laboratories, UCB Pharma, and Vivus Pharmaceuticals. C. Kwon has nothing to disclose. Go to Neurology.org/N for full disclosures.",
year = "2019",
month = jan,
day = "29",
doi = "10.1212/WNL.0000000000006751",
language = "English",
volume = "92",
pages = "213--214",
journal = "Neurology",
issn = "0028-3878",
publisher = "Lippincott Williams and Wilkins",
number = "5",
}